Chickenpox Cases Down 85 Percent Since 2-Dose Vaccine Started: CDC
THURSDAY, Sept. 1, 2016 -- Chickenpox -- which is caused by the varicella-zoster virus -- has continued declining in the United States since 2006, when doctors began routinely recommending a second dose of chickenpox (varicella) vaccine, U.S. health... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 1, 2016 Category: Journals (General) Source Type: news

Varicella Zoster Virus Infection in Neonates
Varicella zoster virus (VZV) can cause a spectrum of clinical manifestations in the fetus and neonate, which range from a self-limited exanthema to congenital malformations and/or death. Once a ubiquitous virus in the community, the epidemiology of VZV has dramatically changed in countries that have introduced the varicella vaccine into their routine immunization schedule. Practitioners must be cautioned against complacency with this virus, however, because unrecognized infection can have far-reaching consequences for the expectant mother, fetus, and neonate. VZV should be included in the differential diagnosis of patients...
Source: NeoReviews recent issues - August 31, 2016 Category: Pediatrics Authors: Petersen, R., Miller, A. S. Tags: Pediatric Drug Labeling Update Articles Source Type: news

Zoster Vaccine Quiz: How are We Doing?
We are 10 years into the Zostavax life cycle. Find out how the shingles vaccine is performing and what you know about it. (Source: ConsultantLive)
Source: ConsultantLive - July 14, 2016 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Vaccines Source Type: news

Could Zostavax use a Booster?
Who gets the best protection from Zostavax and how long does it last? Is that enough? (Source: ConsultantLive)
Source: ConsultantLive - July 14, 2016 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Vaccines Source Type: news

Intradermal Varicella-Zoster Vaccine Elicits Greater Antibody ResponseIntradermal Varicella-Zoster Vaccine Elicits Greater Antibody Response
Intradermal administration of varicella-zoster virus vaccine elicits a greater antibody response in older adults than does subcutaneous administration at comparable doses, researchers have reported. Reuters Health Information (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 28, 2016 Category: Infectious Diseases Tags: Public Health & Prevention News Source Type: news

Vaccines for preventing herpes zoster in older adults - new Cochrane Review
The review concludes that Herpes zoster vaccine is effective in preventing herpes zoster disease, and this protection can last three years. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse events of mild to moderate intensity.There are studies of a new vaccine (with a VZV glycoproteic fraction plus adjuvant), which is currently not yet available for clinical use. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 5, 2016 Category: Consumer Health News Source Type: news

Featured Review: Vaccines for preventing herpes zoster in older adults
Vaccine helps prevent shingles in older adults for up to three years The varicella zoster virus causes chickenpox and can remain dormant inside nerve cells. After many years, it can reactivate and travel through the nerve to the skin, causing itching, numbness, tingling or local pain, and then blisters along the nerve path. These blisters are often accompanied with inflammation of the nerves and severe pain, which can affect quality of life. This is called herpes zoster or shingles. It affects people with low immunity such as older people. There are about 5.22 episodes of shingles for every 1000 older people. This is ...
Source: Cochrane News and Events - March 21, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

As varicella recedes, zoster rises: The question is ‘why?’
WASHINGTON – As the number of children vaccinated against varicella has risen, the number of chicken pox cases has proportionally declined. No news there. But, as the number of kids getting... (Source: Pediatric News)
Source: Pediatric News - March 13, 2016 Category: Journals (General) Source Type: news

Shingles: questions and answers for healthcare professionals
A universal routine herpes zoster (shingles) vaccination programme for adults aged over 70 years started in September 2013. (Source: NHS Networks)
Source: NHS Networks - February 25, 2016 Category: UK Health Source Type: news

Don’t shrug off shingles
If you had chickenpox as a kid, there is a good chance you may develop shingles later in life. “In fact, one in three is predicted to get shingles during their lifetime,” says Dr. Anne Louise Oaklander, director of the Nerve Unit at Harvard-affiliated Massachusetts General Hospital. The same varicella-zoster virus that causes chickenpox also causes shingles. After the telltale spots of chickenpox vanish, the virus lies dormant in your nerve cells near the spinal cord and brain. When your immunity weakens from normal aging or from illnesses or medications, the virus can re-emerge. It then travels along a nerve to trigge...
Source: New Harvard Health Information - February 18, 2016 Category: Consumer Health News Authors: Matthew Solan Tags: Healthy Aging Infectious diseases Vaccines Source Type: news

Chickenpox, shingles vaccine may cause corneal inflammation in some patients
In use for more than 20 years, the varicella zoster virus vaccine for chickenpox and shingles is considered an essential medicine by the World Health Organization (WHO). However, researchers have found, in rare instances, a link between the vaccine and corneal inflammation. It is a finding the researchers say should be discussed by primary care physicians and patients with a history of eye inflammation before getting vaccinated. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 20, 2016 Category: Science Source Type: news

Chickenpox, shingles vaccine may cause corneal inflammation in some patients
(University of Missouri-Columbia) In use for more than 20 years, the varicella zoster virus vaccine for chickenpox and shingles is considered an essential medicine by the World Health Organization (WHO). However, researchers from the University of Missouri School of Medicine have found, in rare instances, a link between the vaccine and corneal inflammation. It is a finding the researchers say should be discussed by primary care physicians and patients with a history of eye inflammation before getting vaccinated. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 20, 2016 Category: Infectious Diseases Source Type: news

Shingles Risk 70% Higher for Adults With AsthmaShingles Risk 70% Higher for Adults With Asthma
Researchers suggest considering zoster vaccine for those aged 50 years and older with asthma. Their findings build on their previous work showing a link between childhood asthma and shingles. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - January 6, 2016 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Medical News Today: Asthma linked to increased risk of shingles
A new study finds that asthma is a risk factor for herpes zoster or shingles in adults and suggests considering the over-50s with asthma as a target group for zoster vaccination. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 29, 2015 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Second dose of herpes zoster vaccine beneficial to seniors
The herpes zoster vaccine should be administered earlier rather than later in order to achieve optimal immune response, but an additional booster shot for individuals 70 years or older is also advisable. This is according to a recent study published in the Journal of Infectious Diseases, which... (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 19, 2015 Category: Dermatology Source Type: news